Pulse Biosciences, Inc. Number of Reporting Units
Pulse Biosciences, Inc. (PLSE) reported Number of Reporting Units of 100.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2025-03-31
- Pulse Biosciences, Inc. number of reporting units for fiscal 2024 was 100.00%.
| Period end | Number of Reporting Units 12 month |
|---|---|
| 2024-12-31 | 100.00% 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |